Australia has taken a positive step towards improving how premenstrual dysphoric disorder (PMDD) is recognised and understood within the healthcare system.
On 29 July 2026, the Australian Institute of Health and Welfare (AIHW) published How to tell the story: A strategy for monitoring sexual and reproductive health data in Australia.
The strategy explicitly includes PMDD among the menstrual health conditions requiring better national data.
While this does not introduce new treatments or services, it acknowledges an important gap in Australia's understanding of PMDD and other menstrual health conditions.
Why does this matter for PMDD?
PMDD is a severe, cyclical condition associated with sensitivity to normal hormonal changes before menstruation. Symptoms can include significant depression, anxiety, irritability and emotional distress. They typically emerge in the second half of the menstrual cycle and improve shortly after menstruation begins.
Despite its substantial impact, Australia lacks comprehensive national data on how many people experience PMDD.
The AIHW strategy identifies premenstrual distress, including PMDD, as an area requiring national prevalence estimates.
PMDD is included within a broader menstrual health topic covering conditions such as endometriosis, adenomyosis, heavy menstrual bleeding and pelvic pain.
What does the strategy propose?
The strategy identifies nine significant gaps in Australia's menstrual health data.
Its priorities include:
Prevalence: Establishing national estimates for several conditions, explicitly including premenstrual distress and PMDD.
Mental health and wellbeing: Measuring how menstrual conditions affect psychological health, relationships, education, employment and daily life.
Diagnosis and treatment: Understanding diagnostic delays, healthcare pathways, treatment use and patient experiences.
Healthcare knowledge: Assessing professional training and public understanding of menstrual health, including health literacy among young people, parents and LGBTQIA+ communities.
Financial costs: Monitoring out-of-pocket expenses for appointments, tests, procedures and medication.
National standards: Improving consistency in how menstrual conditions are defined and recorded.
These priorities apply to menstrual health conditions collectively, rather than representing a PMDD-specific action plan.
Recognition is a beginning, not the outcome
One important limitation is that developing validated diagnostic tools and implementing consistent diagnostic coding remain outside the strategy's current work program.
This is particularly relevant to PMDD, where diagnosis generally requires prospective symptom tracking across at least two menstrual cycles.
The AIHW acknowledges that improving these systems will require collaboration between clinical experts, organisations responsible for health data and other stakeholders.
The strategy is not a commitment to additional PMDD funding or services. However, better national information could eventually support more informed healthcare planning, clinical education and research.
For people living with PMDD, the real measure of progress will be whether greater recognition leads to earlier diagnosis, knowledgeable healthcare professionals and better access to effective treatment.
That remains the work ahead.
Further information and support
Progressive Therapeutic Counselling provides inclusive, gender-affirming therapeutic support for people experiencing PMDD and other menstrual health difficulties.
Learn more about PMDD and menstrual health counselling at PTC.
If you are experiencing significant distress or suicidal thoughts:
Lifeline Australia: 13 11 14, available 24 hours a day.
International Association for Premenstrual Disorders (IAPMD): iapmd.org, for PMDD information and peer support.
Immediate danger: Call 000.
Original source
Australian Institute of Health and Welfare (29 July 2026). How to tell the story: A strategy for monitoring sexual and reproductive health data in Australia.
Read the original AIHW report, including its menstrual health priorities.
Disclaimer: This article is provided for general education and information. It does not replace individual medical advice, diagnosis or treatment. If you are concerned about PMDD symptoms, consult an appropriately qualified healthcare professional.